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Abstract
The objective of this study was to determine the prevalence and distribution of methicillin-resistant Staphylococcus aureus (MRSA) genotypes
circulating at a tertiary hospital in the Sultanate of Oman. A total of 79 MRSA isolates were obtained from different clinical samples and
investigated using antibiogram, pulsed-ﬁeld gel electrophoresis (PFGE), staphylococcal chromosome cassette mec (SCCmec), Spa typing and
multilocus sequence typing (MLST). The isolates were susceptible to linezolid, vancomycin, teicoplanin, tigecycline and mupirocin but were
resistant to tetracycline (30.4%), erythromycin (26.6%), clindamycin (24.1%), trimethoprim (19.0%), ciproﬂoxacin (17.7%), fusidic acid
(15.2%) and gentamicin (12.7%). Molecular typing revealed 19 PFGE patterns, 26 Spa types and 21 sequence types. SCCmec-IV (86.0%) was
the dominant SCCmec type, followed by SCCmec-V (10.1%). SCCmec-III (2.5%) and SCCmec-II (1.3%) were less common. ST6-IV/t304
(n = 30) and ST1295-IV/t690 (n = 12) were the dominant genotypes followed by ST772-V/t657 (n = 5), ST30-IV/t019/t021 (n = 5),
ST22-IV/t852 (n = 4), ST80-IV/t044 (n = 3) and 18 single genotypes that were isolated sporadically. On the basis of SCCmec typing and
MLST, 91.2% of the isolates were classiﬁed as community-associated MRSA and 8.8% of the isolates (consisting of four ST22-IV/t852, one
ST239-III/t632, one ST5-III/t311 and one ST5-II/t003) were classiﬁed as healthcare-associated MRSA. The study has revealed the dominance
of a Panton–Valentine leucocidin-negative ST6-IV/t304 clone and provided insights into the distribution of antibiotic resistance in MRSA at
the tertiary hospital in Oman. It also highlights the importance of surveillance in detecting the emergence of new MRSA clones in a
healthcare facility.
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The burden of infections caused by methicillin-resistant
Staphylococcus aureus (MRSA) is increasing among different
patient populations globally [1–3]. Following its initial report in
1961 [4], MRSA has remained an important cause of infections
in healthcare facilities and in the community globally [1–3].
Although previously restricted to healthcare facilities,
especially large tertiary-care facilities [5], MRSA has been
increasingly identiﬁed as a major cause of community-associ-
ated infections in previously healthy hosts since the late 1990s
[6–8]. These new MRSA strains have been described as
community-acquired or community-originated MRSA. Com-
munity-acquired MRSA can be distinguished from healthcare-
associated MRSA isolates on the basis of patient risk factors
such as history of previous hospitalization, previous antibiotic
treatment, admission to intensive care units, advanced age,
location at the time of infection and genetic characteristics
[6,7].
Advances in molecular typing techniques, including
pulsed-ﬁeld gel electrophoresis (PFGE) [9], staphylococcal
cassette chromosome mec (SCCmec) [10], Spa typing [11,12]
and multilocus sequence typing (MLST) [13] have facilitated the
study of clonal distributions of MRSA strains isolated in
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different countries and revealed a diversity in the genetic
backgrounds of MRSA isolated in different geographical
locations [14]. In addition to the capacity to acquire
antibiotic-resistance determinants, some MRSA strains have
also acquired the ability to spread rapidly between patients
within and between hospitals, thereby causing major problems
for infection control. Hence, some epidemic MRSA strains
have spread internationally [14]. For example, the epidemic
MRSA clones ST239-MRSA-III, ST22-MRSA-IV and
ST30-MRSA-IV are widely distributed globally [8] whereas
the USA300 MRSA is the dominant MRSA clone in North
America and another MRSA clone, the ST80-MRSA-IV clone, is
distributed widely in European countries, North Africa, the
Middle East and the Gulf Cooperation Council (GCC)
countries [15].
Studies on the distribution of MRSA clones in the GCC
countries are limited [15–18]. Although MRSA has been
reported in the Sultanate of Oman since 1995 [19], there are
no data on the MRSA genotypes prevalent in the country. This
study was conducted to determine the prevalence and




The Sultan Qaboos University Hospital (SQUH) is a 550-bed
teaching hospital of the Sultan Qaboos University. The hospital
has 13 different medical departments, which include Surgery,
Oral Health, Ophthalmology, Obstetrics & Gynaecology,
Medicine, Human Clinical Anatomy, Haematology, Genetics,
Family Medicine and Public Health, Emergency Medicine, Child
Health, Behavioural Medicine, Anaesthesia and Intensive Care
in addition to technical departments.
MRSA isolates
A total of 79 non-repeat MRSA isolates obtained from clinical
samples between March and December 2011 at the SQUH
were investigated. Isolation and identiﬁcation of MRSA from
clinical samples were performed in the diagnostic microbiol-
ogy laboratory of SQUH based on cultural characteristics,
Gram stain, positive tube coagulase and DNAse tests.
Methicillin resistance was conﬁrmed by the ampliﬁcation of
mecA as described previously [20]. The isolates were obtained
from samples listed in Table 1. Pure cultures of the isolates
were preserved in Cryo-bank vials at 80°C. Molecular typing
was performed at the Department of Microbiology, Health
Science Centre, Kuwait University, Kuwait.
Antibacterial susceptibility testing
Antibacterial susceptibility testing was performed by the disc
diffusion method [21] with the following antimicrobial disks
(Oxoid, Basingstoke, UK): benzyl penicillin (2 U), cefoxitin
(30 lg), kanamycin (30 lg), mupirocin (200 lg and 5 lg),
gentamicin (10 lg), erythromycin (15 lg), clindamycin
(2 lg), chloramphenicol (30 lg), tetracycline (10 lg), tri-
methoprim (2.5 lg), fusidic acid (10 lg), rifampicin (5 lg),
ciproﬂoxacin (5 lg), teicoplanin (30 lg), vancomycin (30 lg)
and linezolid (30 lg). Discs containing cadmium acetate
(50 lg), propamidine isethionate (100 lg) and mercuric
chloride (109 lg) were prepared in the laboratory. Minimum
inhibitory concentration (MIC) for cefoxitin, vancomycin and
teicoplanin were determined with E-test strips (AB
BioMerieux, Marcy l’Etoile, France) according to the man-
ufacturer’s instructions. Staphylococcus aureus strain
ATCC25923 was used as a quality control strain for
susceptibility testing.
SCCmec typing
SCCmec typing was performed by PCR assays as described
previously [22,23].
Detection of genes for Panton–Valentine leucocidin
All isolates were tested for the presence of lukS-PV-lukF-PV,
which codes for Panton–Valentine leucocidin (PVL), in PCR
assays using previously described primers and protocols
[24,25]. PCR products were analysed by agarose gel electro-
phoresis.
TABLE 1. Association of Panton–Valentine leucoci-
din-positive (PVL+) methicillin-resistant Staphylococcus aur-
eus isolates with different types of infections
Types of infection
No. of
strains No. (%) of PVL+
Skin and soft tissue infections 29 21 (72.4)
Abscess 19 14 (73.7)
Ulcera 4 2 (50)
Skin lesions/boils/furuncles 3 3 (100)
Folliculitis 1 1 (100)
Cellulitis 1 0 (0.0)
Blisters 1 1 (100)
Wounds 22 9 (40.9)
Postsurgical 11 3 (27.3)
Trauma 11 6 (54.5)
Respiratory tract infections 11 0
Pneumonia 4 0 (0.0)
Othersb 7 0 (0.0)
Septicaemia/bacteraemia 6 3 (50)




Colonizationc 4 0 (0.0)
Total 79 35 (44.3)
aBed Sore, pressure sore, mouth and groin ulcers and diabetic foot ulcer.
bIncluding cystic ﬁbrosis.
cNasal and umbilical.
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Pulsed-ﬁeld gel electrophoresis
The PFGE of SmaI-digested chromosomal DNA was per-
formed as described previously [26]. PFGE patterns were
compared using BIOINFORMATICS FPQUEST software version 4.0
software (BioRad, Hercules, CA, USA) and Dice correlation
coefﬁcients, with optimization and band position tolerance set
at 1.0% and 2.3%, respectively [27].
Spa typing
Spa typing was performed as described by Harmsen et al.
[12] for all MRSA isolates. DNA sequencing was performed
using a 313091 genetic analyser (Applied Biosystems, Foster
City, CA, USA) in accordance with the manufacturer’s
protocol. Isolates were assigned to particular Spa types
using the Spa typing website (http://www.spaserver.ridom.
de).
Multilocus sequence typing
The MLST was performed on all isolates as described by
Enright et al. [13]. Isolates were assigned a sequence type (ST)
according to the MLST website (http://www.mlst.net).
Results
The 79 MRSA isolates were obtained from 46 male patients
and 33 female patients. Forty-three patients were 19–59 years
old, 26 patients were ≤18 years old and ten patients were
≥60 years.
Thirty-ﬁve (44.3%) MRSA isolates were positive for the
presence of lukS-PV-lukF-PV, mostly in isolates that were
associated with skin and soft tissue infections and septicaemia
but not in isolates recovered from colonization or respiratory
tract specimens (Table 1).
Antibiotic resistance of MRSA isolates
All 79 MRSA isolates were susceptible to vancomycin
(MIC ≤ 2 mg/L), teicoplanin (MIC ≤ 2 mg/L), linezolid, tigecy-
cline and mupirocin but were resistant to tetracycline
(n = 24), erythromycin (n = 21), clindamycin (n = 19), kana-
mycin (n = 17), trimethoprim (n = 15), ciproﬂoxacin (n = 14)
and fusidic acid (n = 12; 15.2%), gentamicin (n = 10) and
streptomycin (n = 6). One isolate was resistant to chloram-
phenicol. Sixteen isolates expressed inducible resistance to
clindamycin.
All 79 isolates were resistant to mercuric chloride and 68
(86.1%) isolates were resistant to ethidium bromide and
cadmium acetate. Nine isolates were resistant to more than
three classes of non-b-lactam antibiotics tested and were
classiﬁed as multiresistant isolates.
Molecular typing of MRSA isolates
Table 2 summarizes the results typing the 79 MRSA isolates
using PFGE, SCCmec, Spa typing and MLST. The isolates were
TABLE 2. Characteristics of methicillin-resistant Staphylo-








1 20 Cd, Hg, Eb IV t304 ST6 neg
1 Hg IV t304 ST6 neg
1 Cd, Hg IV t304 ST6 neg
1 Cd, Hg, Em, Clin IV t304 ST6 neg
1 Cd, Hg, Eb, Fd IV t304 ST6 neg
1 Hg, Em, Clin IV t304 ST6 neg
3 Hg, Eb IV t304 ST6 neg
1 Cd, Hg IV t7966 ST6 neg
2 5 Cd, Hg, Eb, Tet IV t690 ST1295 pos (4)
2 Cd, Hg, Eb, Tet, Em,
Clin,
IV t690 ST1295 pos (1)
3 Cd, Hg, Eb, Tet, Cip IV t690 ST1295 pos (3)
1 Cd, Hg, Eb IV t690 ST1295 pos
1 Cd, Hg, Tet, Fd IV t690 ST1295 pos
3 1 Cd, Hg, Eb, Gm, Km,
Sm, Tet, Fd
IV t044 ST80 neg
1 Cd, Hg, Eb, Km, Sm,
Tet, Em, Clin, Fd
IV t044 ST80 pos
1 Cd,Hg, Eb, Km, Sm,
Tet, Fd
IV t044 ST80 pos
1 Cd, Hg, Eb, Tet, Em,
Clin
IV t8154 ST450 neg
1 Cd, Hg, Eb, Km, Em,
Clin
IV t304 ST6 pos
1 Cd, Hg, Eb, Km, Sm,
Tet, Fd
IV t304 ST6 pos
4 4 Cd, Hg, Gm, Km, Em,
Clin, Tp, Cip
V t657 ST772 pos
1 Cd, Hg, Eb, Gm, Km,
Em, Clin, Tp, Cip
V t657 ST772 pos
1 Cd, Hg, Eb, Gm, Km,
Em, Tp
V t2085 ST573 pos
5 1 Hg, Em, Clin, Tp, Cip, IV t852 ST22 pos
1 Hg, Eb, Em, Clin, Tp IV t852 ST22 pos
1 Hg,Gm,Km,Em, Clin,
Tp, Cip
IV t852 ST22 pos
1 Cd,Hg,Eb, Gm,Km,
Tp, Cip
IV t852 ST22 pos
6 1 Hg, Eb, Fd, Em, Clin IV t002 ST5 pos
1 Cd, Hg, Eb IV t002 ST5 pos
1 Hg, Eb, Km, Sm, Em,
Clin, Fd
II t003 ST5 neg
1 Cd, Hg, Eb, Tet IV t855 ST628 pos
1 Cd, Hg, Eb, Tet, Tp,
Em, Clin, Cip
IV t442 ST487 neg
7 1 Cd, Hg, Eb IV t021 ST30 neg
3 Cd, Hg, Eb IV t019 ST30 pos
1 Cd, Hg, Eb, Tet, Tp,
Fd
IV t019 ST30 pos
8 1 Cd, Hg, Tet IV t5686 ST188 neg
9 2 Cd, Hg, Eb, Km, Sm,
Em, Clin, Cip
V t315 ST361 neg
10 1 Cd, Hg, Eb, Tet, Cm V t688 ST627 neg
11 1 Cd,Hg, Eb IV t4447 ST631 neg
12 1 Cd, Hg, Eb, Em, Clin,
Fd, Tp, Cip
III t311 ST5 pos
13 1 Cd, Hg, Eb, Em, Clin,
Fd
IV t127 ST1 neg
14 1 Cd, Hg, Eb, Gm, Km,
Em, Clin, Tet, Rf, Cip
III t632 ST239 neg
15 1 Cd, Hg, Eb, Em, Clin,
Tet, Tp, Cip
IV t064 ST8 neg
16 1 Cd, Hg, Eb, Em, Clin, Fd IV t311 ST1197 pos
17 1 Cd, Hg, Eb, Km, Em,
Clin, Cip
IV t150 ST585 pos
18 1 Cd, Hg, Eb, Tet, Em, Clin IV t8213 ST63 pos
19 1 Hg, Eb, Tp IV t401 ST1802 neg
Antimicrobials abbreviations:
Cd, cadmium acetete; Clin, clindamycin; Cip, ciproﬂoxacin; Cm, chloramphenicol;
Eb, ethidium bromide; Fd, fusidic acid; Gm, gentaimicn; Hg, mecuric chloride; Km,
kanamycin; Rf, rifampicin; Sm, streptomycin; Tet, tetracycline; Tp, trimethoprim;
MLST, multilocus sequence typing; PFGE, pulsed-ﬁeld gel electrophoresis; PVL,
Panton -Valentine Leucocidin; SCCmec, staphylococcal chromosome cassette mec.
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classiﬁed into 19 PFGE patterns (Fig. 1), four SCCmec types, 25
Spa types and 21 sequence types.
Sixty-eight (86.0%) of the 79 isolates carried the SCCmec-IV
genetic element while eight isolates (10.1%) carried
SCCmec-V. Two isolates carried SCCmec-III and only one
isolate carried SCCmec-II. SCCmec-I was not detected. A
combination of the typing results revealed that ST6-IV/t304
(n = 30) was the most common genotype followed by
ST1295-IV/t690 (n = 12), ST772-V/t657 (n = 5), ST22-IV/
t852 (n = 4), ST30-IV/t019 (n = 4), ST80-IV/t044 (n = 3),
ST5-IV/t002 (n = 2) and 15 sporadic genotypes. Based on
these results, seven (8.8%) isolates consisting of four ST22-IV/
t852, one ST239-III/t632, one ST5-III/t311 and one ST5-II/t003
were recognized healthcare-associated MRSA and 72 (91.2%)
isolates that carried SCCmec-IV (n = 67) or SCCmec-V
(n = 5) genetic elements were community-acquired MRSA.
FIGURE 1. Dendrogram of pulsed-ﬁeld gel electrophoresis patterns of methicillin-resistant Staphylococcus aureus isolates obtained from SQUH
Oman.
ª 2014 The Authors. New Microbes and New Infections published by John Wiley & Sons Ltd on behalf of the European Society of Clinical Microbiology and Infectious Disease., NMNI, 2, 100–105
NMNI Udo et al. Genotyping of MRSA in Oman 103
Open access under CC BY license.
Discussion
This study has provided initial data on the prevalence and
distribution of MRSA genotypes in the SQUH, a major tertiary
hospital in the Sultanate of Oman. The MRSA isolates belonged
to diverse genetic backgrounds with ST6-IV/t304 clone,
detected in 39.2% of the isolates, as the dominant clone. The
dominance of the ST6-IV/t304 clone at the SQUH in Oman
was different from the situation in Saudi Arabia [15] and Qatar
[18] where ST239-III-MRSA and ST30-IV-MRSA were the
dominant MRSA clones, respectively. However, before this
report, two ST6-IV/t304 strains were isolated at Tawam
Hospital in the United Arab Emirates (UAE) in 2008 [16].
Interestingly, 28 of our ST6-IV/t304 isolates lacked genes for
PVL and were susceptible to non-b-lactam antibiotics similar
to characteristics of the strains from the UAE hospital [16].
These observations may indicate the expansion of this clone in
the GCC countries.
The other common MRSA clones detected in this study,
ST30-IV/t019/t021, ST80-IV/t044, ST772-V/t657, ST5-IV/t002
and ST22-IV/t852 have also been reported previously in
other GCC countries [15–18]. However, although
ST22-IV-MRSA has been reported previously in Saudi Arabia
[15], Kuwait [7,17], UAE [16] and Qatar [18], the
PVL-positive ST22-IV/t852 clones reported here share
similarities with ST22-IV/t852 reported recently in Qatar
[18] but differ from the ST22-IV/t005 isolated in the UAE
[16]. Furthermore, three of our four ST22-IV/t852 isolates
were multidrug-resistant whereas ST22-IV, reported previ-
ously from Kuwait [17] and UAE [16], were PVL-negative
and non-multiresistant. Therefore the ST22-IV/t852 strains
may represent an emerging multiresistant variant of ST22-IV
MRSA.
The results also showed that only 8.8% of the isolates—
belonging to ST239-III, ST5-II, ST5-III and ST22-IV clones—
were healthcare-associated MRSA. Therefore, 91.2% of the
isolates carrying SCCmec-IV/V genetic elements were com-
munity-acquired MRSA. These reports highlight differences in
the prevalence of MRSA clones in the GCC countries,
strengthening the need for national surveillance for the
clonal distribution of antibiotic-resistant pathogens in these
countries.
The study also revealed that 44.3% of the isolates carried
genes for PVL. This was higher than the 14.6% PVL
gene-positive MRSA reported recently in a Kuwait hospital
[28] but lower than the 54.2% positive rate obtained in a Saudi
Arabian hospital [15], indicating the diversity of MRSA bearing
PVL genes in the GCC countries. PVL gene-positive S. aureus
have been associated with necrotic skin lesions and commu-
nity-acquired necrotic pneumonia [24]. In this study PVL
gene-positive MRSA were obtained from skin and soft tissue
infections but not from respiratory tract infections. However,
the signiﬁcance of this observation is uncertain because of the
small number of MRSA isolated from respiratory tract.
In conclusion, this study has presented the ﬁrst data on the
distribution of MRSA genotypes at the SQUH in Oman. The
MRSA isolates belonged to diverse genetic backgrounds with a
predominance of CA-MRSA clones comprising ST6-IV/t304
and ST1295-IV/t690, followed by ST772-V/t657, ST30-IV/t019/
t021 and ST80-IV/t044.
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